register

News & Trends - Pharmaceuticals

Latest developments set to transform the future management of retinal disease: A clinical and patient perspective

Health Industry Hub | August 24, 2022 |

Pharma News: A recent TGA registration and positive Pharmaceutical Benefits Advisory Committee (PBAC) recommendation has prompted a deeper conversation on a significant cause of vision loss impacting many Australians.

Professor Paul Mitchell, ophthalmologist and Director of the Centre For Vision Research at The Westmead Institute for Medical Research, and Dr Kathy Chapman, CEO of Macular Disease Foundation Australia (MDFA), joined Health Industry Hub to discuss the key barriers for patients in accessing and remaining adherent to current therapies for neovascular or ‘wet’ age-related macular degeneration (nAMD) and diabetic retinopathy.

Professor Mitchell shared his insights on novel treatments that have the potential to transform the future diagnosis and management of these eye conditions to reduce the burden of disease. He commented on his team’s research focus and also the breakthrough research that will be presented at the upcoming AAO 2022 congress.

Dr Chapman and Professor Mitchell reflected on how industry can work better with patient advocacy groups, clinicians and academia in integrating the patient voice in research, regulatory and health technology assessment (HTA) activities.

MDFA is continuing to engage with the new government from an advocacy perspective to drive necessary policy changes and funding requirements. Dr Chapman commented on the areas of significance for this year.


News & Trends - MedTech & Diagnostics

Government commissions review as 70% of private hospitals face financial crisis

Government commissions review as 70% of private hospitals face financial crisis

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: Despite playing a crucial role in providing acute care and surgical services, a staggering 70% of […]

More


News & Trends - Pharmaceuticals

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Health Industry Hub | June 14, 2024 |

Pharma News: The Pharmacy Guild of Australia has echoed the significant concerns of the Australian Competition and Consumer Commission (ACCC) […]

More


News & Trends - MedTech & Diagnostics

Competition watchdog raises concerns over cancer care provider's expansion plans

Competition watchdog raises concerns over cancer care provider’s expansion plans

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: A leading provider of cancer care services in Australia, faces scrutiny from the Australian Competition and […]

More


News & Trends - Biotechnology

Aussie biotech secures first local CAR T patent

Aussie biotech secures first local CAR T patent

Health Industry Hub | June 13, 2024 |

Biotech News: A Melbourne-based biotechnology company which specialises in developing immune cell therapies for cancer treatment, has been granted its […]

More


This content is copyright protected. Please subscribe to gain access.